US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist
  • 2.280
  • +0.200+9.62%
Close Dec 20 16:00 ET
  • 2.290
  • +0.010+0.44%
Post 17:28 ET
13.00MMarket Cap-0.66P/E (TTM)

About Brainstorm Cell Therapeutics Company

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.

Company Profile

SymbolBCLI
Company NameBrainstorm Cell Therapeutics
Listing DateMay 9, 2003
Founded2000
CEOMr. Chaim Lebovits
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address1325 Avenue of Americas,28th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-201-488-0460
Websitehttp://www.brainstorm-cell.com

Company Executives

  • Name
  • Position
  • Salary
  • Chaim Lebovits
  • President and Chief Executive Officer
  • 1.13M
  • Dr. Haro Hartounian, PhD
  • Executive Vice President and Chief Operating Officer
  • --
  • Uri Yablonka
  • Director, Executive Vice President, Chief Business Officer and Secretary
  • 247.06K
  • Dr. Ibrahim B. Dagher
  • Executive Vice President and Chief Medical Officer
  • --
  • Alla Patlis, C.P.A.,M.B.A.
  • Interim Chief Financial Officer, Principal Accounting Officer and Controller
  • 146.78K
  • Dr. Hartoun Hartounian, PhD
  • Executive Vice President and Chief Operating Officer
  • --
  • Dr. Jacob A. Frenkel, M.A.,PhD
  • Chairman of the Board
  • 152.81K
  • Dr. Irit Arbel, PhD
  • Vice Chairman of the Board
  • --
  • Dr. Stacy R. Lindborg, PhD
  • Director
  • 1.01M
  • Dr. Anthony J. Polverino, PhD
  • Independent Director
  • 12.50K
  • Nir Naor
  • Independent Director
  • --
  • Dr. Menghisteab Bairu
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data